Noninvasive Molecular Imaging of Disease Activity in Atherosclerosis

Circulation Research

Volumn 119, Issue 2, 2016, Pages 330-340

  Dweck, Marc R ^a,b   Aikawa, Elena ^c   Newby, David E ^b   Tarkin, Jason M ^d   Rudd, James H F ^d   Narula, Jagat ^a   Fayad, Zahi A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

18F Fluorodeoxyglucose; Atherosclerosis; Disease progression; Inflammation; Myocardial infarction

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IRON OXIDE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11;

ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CARDIAC PATIENT; CLINICAL TRIAL (TOPIC); DISEASE ACTIVITY; HUMAN; HYBRID; INFLAMMATION; MOLECULAR IMAGING; MULTICENTER STUDY (TOPIC); NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; DIAGNOSTIC IMAGING; DISEASE COURSE; METABOLISM; PROCEDURES;

ATHEROSCLEROSIS; DISEASE PROGRESSION; HUMANS; MOLECULAR IMAGING; POSITRON-EMISSION TOMOGRAPHY; VASCULAR CALCIFICATION;

EID: 84978110431     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.307971     Document Type: Review

References (90)

1. Naghavi M, Libby P, Falk E, From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003 108 1664 1672. doi: 10.1161/01.CIR.0000087480.94275.97
2. Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M, Borrico S, Gorlin R, Fuster V, Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988 12 56 62
3. Falk E, Shah PK, Fuster V, Coronary plaque disruption. Circulation 1995 92 657 671
4. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, Mehran R, McPherson J, Farhat N, Marso SP, Parise H, Templin B, White R, Zhang Z, Serruys PW, PROSPECT Investigators A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011 364 226 235. doi: 10.1056/NEJMoa1002358
5. Calvert PA, Obaid DR, O'Sullivan M, Shapiro LM, McNab D, Densem CG, Schofield PM, Braganza D, Clarke SC, Ray KK, West NE, Bennett MR, Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) Study. JACC Cardiovasc Imaging 2011 4 894 901. doi: 10.1016/j.jcmg.2011.05.005
6. Motoyama S, Ito H, Sarai M, Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up. J Am Coll Cardiol 2015 66 337 346. doi: 10.1016/j.jacc.2015.05.069
7. Ahmadi A, Leipsic J, Blankstein R, Taylor C, Hecht H, Stone GW, Narula J, Do plaques rapidly progress prior to myocardial infarction? The interplay between plaque vulnerability and progression. Circ Res 2015 117 99 104. doi: 10.1161/CIRCRESAHA.117.305637
8. Kaul S, Narula J, In search of the vulnerable plaque: is there any light at the end of the catheter? J Am Coll Cardiol 2014 64 2519 2524. doi: 10.1016/j.jacc.2014.10.017
9. Hutcheson JD, Goettsch C, Bertazzo S, Maldonado N, Ruiz JL, Goh W, Yabusaki K, Faits T, Bouten C, Franck G, Quillard T, Libby P, Aikawa M, Weinbaum S, Aikawa E, Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques. Nat Mater 2016 15 335 343. doi: 10.1038/nmat4519
10. Mann J, Davies MJ, Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart 1999 82 265 268
11. Arbab-Zadeh A, Nakano M, Virmani R, Fuster V, Acute coronary events. Circulation 2012 125 1147 1156. doi: 10.1161/CIRCULATIONAHA.111.047431
12. Kondos GT, Hoff JA, Sevrukov A, Daviglus ML, Garside DB, Devries SS, Chomka EV, Liu K, Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low-to intermediate-risk adults. Circulation 2003 107 2571 2576. doi: 10.1161/01.CIR.0000068341.61180.55
13. Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ, Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 2003 228 826 833. doi: 10.1148/radiol.2283021006
14. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, Liu K, Shea S, Szklo M, Bluemke DA, O'Leary DH, Tracy R, Watson K, Wong ND, Kronmal RA, Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008 358 1336 1345. doi: 10.1056/NEJMoa072100
15. Øvrehus KA, Schuhbaeck A, Marwan M, Achenbach S, Nørgaard BL, Bøtker HE, Dey D, Reproducibility of semi-automatic coronary plaque quantification in coronary CT angiography with sub-mSv radiation dose. J Cardiovasc Comput Tomogr 2016 10 114 120. doi: 10.1016/j.jcct.2015.11.003
16. Raggi P, Callister TQ, Shaw LJ, Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy. Arterioscler Thromb Vasc Biol 2004 24 1272 1277. doi: 10.1161/01.ATV.0000127024.40516.ef
17. Noguchi T, Kawasaki T, Tanaka A, Yasuda S, Goto Y, Ishihara M, Nishimura K, Miyamoto Y, Node K, Koga N, High-intensity signals in coronary plaques on noncontrast T1-weighted magnetic resonance imaging as a novel determinant of coronary events. J Am Coll Cardiol 2014 63 989 999. doi: 10.1016/j.jacc.2013.11.034
18. Beer AJ, Pelisek J, Heider P, Saraste A, Reeps C, Metz S, Seidl S, Kessler H, Wester HJ, Eckstein HH, Schwaiger M, PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis. JACC Cardiovasc Imaging 2014 7 178 187. doi: 10.1016/j.jcmg.2013.12.003
19. 18F-fluoromisonidazole positron emission tomographic imaging. Circ Cardiovasc Imaging 2014 7 312 320. doi: 10.1161/CIRCIMAGING.113.001084
20. Libby P, Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001 104 365 372
21. Cheng VY, Slomka PJ, Le Meunier L, Tamarappoo BK, Nakazato R, Dey D, Berman DS, Coronary arterial 18F-FDG uptake by fusion of PET and coronary CT angiography at sites of percutaneous stenting for acute myocardial infarction and stable coronary artery disease. J Nucl Med 2012 53 575 583. doi: 10.2967/jnumed.111.097550
22. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF, Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001 103 415 422
23. Richards JM, Semple SI, MacGillivray TJ, Gray C, Langrish JP, Williams M, Dweck M, Wallace W, McKillop G, Chalmers RT, Garden OJ, Newby DE, Abdominal aortic aneurysm growth predicted by uptake of ultrasmall superparamagnetic particles of iron oxide: a pilot study. Circ Cardiovasc Imaging 2011 4 274 281. doi: 10.1161/CIRCIMAGING.110.959866
24. Alam SR, Shah AS, Richards J, Lang NN, Barnes G, Joshi N, MacGillivray T, McKillop G, Mirsadraee S, Payne J, Fox KA, Henriksen P, Newby DE, Semple SI, Ultrasmall superparamagnetic particles of iron oxide in patients with acute myocardial infarction: early clinical experience. Circ Cardiovasc Imaging 2012 5 559 565. doi: 10.1161/CIRCIMAGING.112.974907
25. Kooi ME, Cappendijk VC, Cleutjens KB, Kessels AG, Kitslaar PJ, Borgers M, Frederik PM, Daemen MJ, van Engelshoven JM, Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003 107 2453 2458. doi: 10.1161/01.CIR.0000068315.98705.CC
26. Tang TY, Howarth SP, Miller SR, The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol 2009 53 2039 2050. doi: 10.1016/j.jacc.2009.03.018
27. Trivedi RA, U-King-Im JM, Graves MJ, Cross JJ, Horsley J, Goddard MJ, Skepper JN, Quartey G, Warburton E, Joubert I, Wang L, Kirkpatrick PJ, Brown J, Gillard JH, In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 2004 35 1631 1635. doi: 10.1161/01.STR.0000131268.50418.b7
28. Rudd JH, Narula J, Strauss HW, Virmani R, Machac J, Klimas M, Tahara N, Fuster V, Warburton EA, Fayad ZA, Tawakol AA, Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J Am Coll Cardiol 2010 55 2527 2535. doi: 10.1016/j.jacc.2009.12.061
29. Irkle A, Vesey AT, Lewis DY, Skepper JN, Bird JL, Dweck MR, Joshi FR, Gallagher FA, Warburton EA, Bennett MR, Brindle KM, Newby DE, Rudd JH, Davenport AP, Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography. Nat Commun 2015 6 7495. doi: 10.1038/ncomms8495
30. Folco EJ, Sheikine Y, Rocha VZ, Christen T, Shvartz E, Sukhova GK, Di Carli MF, Libby P, Hypoxia but not inflammation augments glucose uptake in human macrophages: Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography. J Am Coll Cardiol 2011 58 603 614. doi: 10.1016/j.jacc.2011.03.044
31. Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC, Yates D, LaMuraglia GM, Furie K, Houser S, Gewirtz H, Muller JE, Brady TJ, Fischman AJ, In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006 48 1818 1824. doi: 10.1016/j.jacc.2006.05.076
32. Silvera SS, Aidi HE, Rudd JH, Mani V, Yang L, Farkouh M, Fuster V, Fayad ZA, Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries. Atherosclerosis 2009 207 139 143. doi: 10.1016/j.atherosclerosis.2009.04.023
33. Figueroa AL, Subramanian SS, Cury RC, Truong QA, Gardecki JA, Tearney GJ, Hoffmann U, Brady TJ, Tawakol A, Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology. Circ Cardiovasc Imaging 2012 5 69 77. doi: 10.1161/CIRCIMAGING.110.959478
34. Marnane M, Merwick A, Sheehan OC, Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence. Ann Neurol 2012 71 709 718. doi: 10.1002/ana.23553
35. Figueroa AL, Abdelbaky A, Truong QA, Corsini E, MacNabb MH, Lavender ZR, Lawler MA, Grinspoon SK, Brady TJ, Nasir K, Hoffmann U, Tawakol A, Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events. JACC Cardiovasc Imaging 2013 6 1250 1259. doi: 10.1016/j.jcmg.2013.08.006
36. Moon SH, Cho YS, Noh TS, Choi JY, Kim BT, Lee KH, Carotid FDG Uptake improves prediction of future cardiovascular events in asymptomatic individuals. JACC Cardiovasc Imaging 2015 8 949 956. doi: 10.1016/j.jcmg.2015.06.002
37. Rudd JH, Myers KS, Bansilal S, Machac J, Rafique A, Farkouh M, Fuster V, Fayad ZA, (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol 2007 50 892 896. doi: 10.1016/j.jacc.2007.05.024
38. Tahara N, Kai H, Ishibashi M, Nakaura H, Kaida H, Baba K, Hayabuchi N, Imaizumi T, Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2006 48 1825 1831. doi: 10.1016/j.jacc.2006.03.069
39. Watanabe T, Kawasaki M, Tanaka R, Ono K, Kako N, Saeki M, Onishi N, Nagaya M, Sato N, Miwa H, Arai M, Noda T, Watanabe S, Minatoguchi S, Anti-inflammatory and morphologic effects of pitavastatin on carotid arteries and thoracic aorta evaluated by integrated backscatter trans-esophageal ultrasound and PET/CT: a prospective randomized comparative study with pravastatin (EPICENTRE study). Cardiovasc Ultrasound 2015 13 17. doi: 10.1186/s12947-015-0012-9
40. Ishii H, Nishio M, Takahashi H, Aoyama T, Tanaka M, Toriyama T, Tamaki T, Yoshikawa D, Hayashi M, Amano T, Matsubara T, Murohara T, Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention. Clin Ther 2010 32 2337 2347. doi: 10.1016/j.clinthera.2010.12.001
41. Tawakol A, Singh P, Rudd JH, Soffer J, Cai G, Vucic E, Brannan SP, Tarka EA, Shaddinger BC, Sarov-Blat L, Matthews P, Subramanian S, Farkouh M, Fayad ZA, Effect of treatment for 12 weeks with rilapladib, a lipoprotein-associated phospholipase A2 inhibitor, on arterial inflammation as assessed with 18F-fluorodeoxyglucose-positron emission tomography imaging. J Am Coll Cardiol 2014 63 86 88. doi: 10.1016/j.jacc.2013.07.050
42. STABILITY Investigators White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen M-F, Corbalan R, Dalby AJ, Danchin N, de Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim H-S, Koenig W, Linhart A, Lonn E, Lopez-Sendon J, Manolis AJ, Mohler ER, Nicolau JC, Pais P, Parkhomenko A, Pedersen TR, Pella D, Ramos-Corrales MA, Ruda M, Sereg M, Siddique S, Sinnaeve P, Smith P, Sritara P, Swart HP, Sy RG, Teramoto T, Tse H-F, Watson D, Weaver WD, Weiss R, Viigimaa M, Vinereanu D, Zhu J, Cannon CP, Wallentin L, STABILITY Investigators Darapladib for preventing ischemic events in stable coronary heart disease. N Engl J Med 2014 370 1702 1711. doi: 10.1056/NEJMoa1315878
43. Fayad ZA, Mani V, Woodward M, Kallend D, Abt M, Burgess T, Fuster V, Ballantyne CM, Stein EA, Tardif JC, Rudd JH, Farkouh ME, Tawakol A, dal-PLAQUE Investigators Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet 2011 378 1547 1559. doi: 10.1016/S0140-6736(11)61383-4
44. Schwartz GG, Olsson AG, Abt M, dal-OUTCOMES Investigators Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 2012 367 2089 2099. doi: 10.1056/NEJMoa1206797
45. Joshi NV, Vesey AT, Williams MC, 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet 2014 383 705 713. doi: 10.1016/S0140-6736(13)61754-7
46. Rogers IS, Nasir K, Figueroa AL, Cury RC, Hoffmann U, Vermylen DA, Brady TJ, Tawakol A, Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. JACC Cardiovasc Imaging 2010 3 388 397. doi: 10.1016/j.jcmg.2010.01.004
47. Joshi NV, Toor I, Shah AS, Systemic Atherosclerotic Inflammation Following Acute Myocardial Infarction: Myocardial Infarction Begets Myocardial Infarction. J Am Heart Assoc 2015 4 e001956. doi: 10.1161/JAHA.115.001956
48. Dutta P, Courties G, Wei Y, Myocardial infarction accelerates atherosclerosis. Nature 2012 487 325 329. doi: 10.1038/nature11260
49. Li X, Bauer W, Kreissl MC, Weirather J, Bauer E, Israel I, Richter D, Riehl G, Buck A, Samnick S, Specific somatostatin receptor II expression in arterial plaque: (68)Ga-DOTATATE autoradiographic, immunohistochemical and flow cytometric studies in apoE-deficient mice. Atherosclerosis 2013 230 33 39. doi: 10.1016/j.atherosclerosis.2013.06.018
50. Rominger A, Saam T, Vogl E, Ubleis C, la Fougère C, Förster S, Haug A, Cumming P, Reiser MF, Nikolaou K, Bartenstein P, Hacker M, In vivo imaging of macrophage activity in the coronary arteries using 68Ga-DOTATATE PET/CT: correlation with coronary calcium burden and risk factors. J Nucl Med 2010 51 193 197. doi: 10.2967/jnumed.109.070672
51. Li X, Samnick S, Lapa C, Israel I, Buck AK, Kreissl MC, Bauer W, 68Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factors. EJNMMI Res 2012 2 52. doi: 10.1186/2191-219X-2-52
52. Bird JL, Izquierdo-Garcia D, Davies JR, Rudd JH, Probst KC, Figg N, Clark JC, Weissberg PL, Davenport AP, Warburton EA, Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis. Atherosclerosis 2010 210 388 391. doi: 10.1016/j.atherosclerosis.2009.11.047
53. Gaemperli O, Shalhoub J, Owen DR, Lamare F, Johansson S, Fouladi N, Davies AH, Rimoldi OE, Camici PG, Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography. Eur Heart J 2012 33 1902 1910. doi: 10.1093/eurheartj/ehr367
54. Fujimura Y, Hwang PM, Trout Iii H, Kozloff L, Imaizumi M, Innis RB, Fujita M, Increased peripheral benzodiazepine receptors in arterial plaque of patients with atherosclerosis: an autoradiographic study with [(3)H]PK 11195. Atherosclerosis 2008 201 108 111. doi: 10.1016/j.atherosclerosis.2008.02.032
55. Pugliese F, Gaemperli O, Kinderlerer AR, Lamare F, Shalhoub J, Davies AH, Rimoldi OE, Mason JC, Camici PG, Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography/computed tomography angiography. J Am Coll Cardiol 2010 56 653 661. doi: 10.1016/j.jacc.2010.02.063
56. Tahara N, Mukherjee J, de Haas HJ, 2-deoxy-2-[18F]fluoro-D-mannose positron emission tomography imaging in atherosclerosis. Nat Med 2014 20 215 219. doi: 10.1038/nm.3437
57. Shaw LJ, Narula J, Chandrashekhar Y, The never-ending story on coronary calcium: is it predictive, punitive, or protective? J Am Coll Cardiol 2015 65 1283 1285. doi: 10.1016/j.jacc.2015.02.024
58. Aikawa E, Nahrendorf M, Figueiredo J-L, Swirski FK, Shtatland T, Kohler RH, Jaffer FA, Aikawa M, Weissleder R, Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 2007 116 2841 2850
59. Tintut Y, Patel J, Parhami F, Demer LL, Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 2000 102 2636 2642
60. Shanahan CM, Inflammation ushers in calcification: a cycle of damage and protection? Circulation 2007 116 2782 2785
61. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL, Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 2000 87 1055 1062
62. Hsu HH, Camacho NP, Isolation of calcifiable vesicles from human atherosclerotic aortas. Atherosclerosis 1999 143 353 362
63. Bobryshev YV, Killingsworth MC, Huynh TG, Lord RS, Grabs AJ, Valenzuela SM, Are calcifying matrix vesicles in atherosclerotic lesions of cellular origin? Basic Res Cardiol 2007 102 133 143. doi: 10.1007/s00395-006-0637-9
64. Kapustin AN, Chatrou ML, Drozdov I, Vascular smooth muscle cell calcification is mediated by regulated exosome secretion. Circ Res 2015 116 1312 1323. doi: 10.1161/CIRCRESAHA.116.305012
65. New SE, Goettsch C, Aikawa M, Marchini JF, Shibasaki M, Yabusaki K, Libby P, Shanahan CM, Croce K, Aikawa E, Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcification in atherosclerotic plaques. Circ Res 2013 113 72 77. doi: 10.1161/CIRCRESAHA.113.301036
66. Hutcheson JD, Maldonado N, Aikawa E, Small entities with large impact: microcalcifications and atherosclerotic plaque vulnerability. Curr Opin Lipidol 2014 25 327 332. doi: 10.1097/MOL.0000000000000105
67. Lin TC, Tintut Y, Lyman A, Mack W, Demer LL, Hsiai TK, Mechanical response of a calcified plaque model to fluid shear force. Ann Biomed Eng 2006 34 1535 1541. doi: 10.1007/s10439-006-9182-9
68. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC, Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004 291 210 215. doi: 10.1001/jama.291.2.210
69. Ehara S, Kobayashi Y, Yoshiyama M, Shimada K, Shimada Y, Fukuda D, Nakamura Y, Yamashita H, Yamagishi H, Takeuchi K, Naruko T, Haze K, Becker AE, Yoshikawa J, Ueda M, Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation 2004 110 3424 3429. doi: 10.1161/01.CIR.0000148131.41425.E9
70. Kolodgie FD, Burke AP, Farb A, Gold HK, Yuan J, Narula J, Finn AV, Virmani R, The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol 2001 16 285 292
71. Burke AP, Weber DK, Kolodgie FD, Farb A, Taylor AJ, Virmani R, Pathophysiology of calcium deposition in coronary arteries. Herz 2001 26 239 244
72. Kataoka Y, Puri R, Hammadah M, Duggal B, Uno K, Kapadia SR, Tuzcu EM, Nissen SE, Nicholls SJ, Spotty calcification and plaque vulnerability in vivo: frequency-domain optical coherence tomography analysis. Cardiovasc Diagn Ther 2014 4 460 469. doi: 10.3978/j.issn.2223-3652.2014.11.06
73. Kume T, Okura H, Kawamoto T, Yamada R, Miyamoto Y, Hayashida A, Watanabe N, Neishi Y, Sadahira Y, Akasaka T, Yoshida K, Assessment of the coronary calcification by optical coherence tomography. EuroIntervention 2011 6 768 772. doi: 10.4244/EIJV6I6A130
74. Vengrenyuk Y, Carlier S, Xanthos S, Cardoso L, Ganatos P, Virmani R, Einav S, Gilchrist L, Weinbaum S, A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps. Proc Natl Acad Sci USA 2006 103 14678 14683. doi: 10.1073/pnas.0606310103
75. Kelly-Arnold A, Maldonado N, Laudier D, Aikawa E, Cardoso L, Weinbaum S, Revised microcalcification hypothesis for fibrous cap rupture in human coronary arteries. Proc Natl Acad Sci USA 2013 110 10741 10746. doi: 10.1073/pnas.1308814110
76. Maldonado N, Kelly-Arnold A, Cardoso L, Weinbaum S, The explosive growth of small voids in vulnerable cap rupture; cavitation and interfacial debonding. J Biomech 2013 46 396 401. doi: 10.1016/j.jbiomech.2012.10.040
77. Derlin T, Richter U, Bannas P, Begemann P, Buchert R, Mester J, Klutmann S, Feasibility of 18F-sodium fluoride PET/CT for imaging of atherosclerotic plaque. J Nucl Med 2010 51 862 865. doi: 10.2967/jnumed.110.076471
78. 18F-sodium fluoride accumulation in femoral arteries as a measure of diffuse calcification with cardiovascular risk factors: a PET/CT study. J Nucl Cardiol 2013 20 569 577. doi: 10.1007/s12350-013-9680-8
79. Derlin T, Tóth Z, Papp L, Wisotzki C, Apostolova I, Habermann CR, Mester J, Klutmann S, Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study. J Nucl Med 2011 52 1020 1027. doi: 10.2967/jnumed.111.087452
80. Behesti M, Alavi A, Detection and global quantification of cardiovascular molecular calcification by fluoro 18 fluoride positron emission tomography/computed tomography-A novel concept. Hell J Nucl Med 2011 14 114 120
81. Dweck MR, Jones C, Joshi NV, Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation 2012 125 76 86. doi: 10.1161/CIRCULATIONAHA.111.051052
82. Dweck MR, Khaw HJ, Sng GK, Luo EL, Baird A, Williams MC, Makiello P, Mirsadraee S, Joshi NV, van Beek EJ, Boon NA, Rudd JH, Newby DE, Aortic stenosis, atherosclerosis, and skeletal bone: is there a common link with calcification and inflammation? Eur Heart J 2013 34 1567 1574. doi: 10.1093/eurheartj/eht034
83. Dweck MR, Chow MW, Joshi NV, Williams MC, Jones C, Fletcher AM, Richardson H, White A, McKillop G, van Beek EJ, Boon NA, Rudd JH, Newby DE, Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol 2012 59 1539 1548. doi: 10.1016/j.jacc.2011.12.037
84. Jenkins WS, Vesey AT, Shah AS, Valvular (18)F-Fluoride and (18)F-Fluorodeoxyglucose Uptake Predict Disease Progression and Clinical Outcome in Patients With Aortic Stenosis. J Am Coll Cardiol 2015 66 1200 1201. doi: 10.1016/j.jacc.2015.06.1325
85. Dweck MR, Jenkins WS, Vesey AT, 18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis. Circ Cardiovasc Imaging 2014 7 371 378. doi: 10.1161/CIRCIMAGING.113.001508
86. Pawade TA, Newby DE, Dweck MR, Calcification in Aortic Stenosis: The Skeleton Key. J Am Coll Cardiol 2015 66 561 577. doi: 10.1016/j.jacc.2015.05.066
87. Bucerius J, Hyafil F, Verberne HJ, Slart RH, Lindner O, Sciagra R, Agostini D, Übleis C, Gimelli A, Hacker M, Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis. Eur J Nucl Med Mol Imaging 2016 43 780 792. doi: 10.1007/s00259-015-3259-3
88. Rubeaux M, Joshi N, Dweck MR, Fletcher A, Motwani M, Thomson LE, Germano G, Dey D, Li D, Berman DS, Newby DE, Slomka PJ, Motion correction of 18F-sodium fluoride PET for imaging coronary atherosclerotic plaques. J Nucl Med 2015 57 54 58. doi: 10.2967/jnumed.115.162990
89. Dweck MR, Puntman V, Vesey AT, Fayad ZA, Nagel E, MR imaging of coronary arteries and plaques. JACC Cardiovasc Imaging 2016 9 306 316. doi: 10.1016/j.jcmg.2015.12.003
90. Vesey AT, Dweck MR, Fayad ZA, Utility of combining PET and MR imaging of carotid plaque. Neuroimaging Clin N Am 2016 26 55 68. doi: 10.1016/j.nic.2015.09.005